A PHASE 2A, PLACEBO-CONTROLLED, RANDOMIZED STUDY OF ABT-981, AN ANTI-INTERLEUKIN-1ALPHA AND-1BETA DUAL VARIABLE DOMAIN IMMUNOGLOBULIN, TO TREAT EROSIVE HAND OSTEOARTHRITIS (EHOA)
Author(s):
Kloppenburg, M.; Peterfy, C.; Haugen, I.K.; Kroon, F.; Chen, S.; Wang, L.; Liu, W.; Levy, G.; Fleischmann, R.; Berenbaum, F.; Heijde, D. van der; Medema, J.; Levesque, M.C.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, p. 122-122
